CIBC Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Sell |
3,133
-1,155
| -27% | -$145K | ﹤0.01% | 803 |
|
|
2025
Q1 | $474K | Buy |
4,288
+210
| +5% | +$23.2K | ﹤0.01% | 761 |
|
|
2024
Q4 | $557K | Buy |
4,078
+487
| +14% | +$66.5K | ﹤0.01% | 734 |
|
|
2024
Q3 | $414K | Buy |
3,591
+191
| +6% | +$22K | ﹤0.01% | 783 |
|
|
2024
Q2 | $468K | Buy |
3,400
+153
| +5% | +$21.1K | ﹤0.01% | 749 |
|
|
2024
Q1 | $448K | Buy |
3,247
+7
| +0.2% | +$965 | ﹤0.01% | 746 |
|
|
2023
Q4 | $427K | Sell |
3,240
-229
| -7% | -$30.2K | ﹤0.01% | 744 |
|
|
2023
Q3 | $390K | Buy |
3,469
+48
| +1% | +$5.4K | ﹤0.01% | 746 |
|
|
2023
Q2 | $323K | Buy |
3,421
+3
| +0.1% | +$283 | ﹤0.01% | 795 |
|
|
2023
Q1 | $346K | Buy |
3,418
+325
| +11% | +$32.9K | ﹤0.01% | 767 |
|
|
2022
Q4 | $369K | Sell |
3,093
-1,163
| -27% | -$139K | ﹤0.01% | 760 |
|
|
2022
Q3 | $452K | Buy |
4,256
+12
| +0.3% | +$1.27K | ﹤0.01% | 784 |
|
|
2022
Q2 | $414K | Sell |
4,244
-59
| -1% | -$5.76K | ﹤0.01% | 783 |
|
|
2022
Q1 | $403K | Buy |
4,303
+24
| +0.6% | +$2.25K | ﹤0.01% | 902 |
|
|
2021
Q4 | $364K | Buy |
4,279
+423
| +11% | +$36K | ﹤0.01% | 961 |
|
|
2021
Q3 | $370K | Buy |
3,856
+338
| +10% | +$32.4K | ﹤0.01% | 920 |
|
|
2021
Q2 | $342K | Buy |
3,518
+6
| +0.2% | +$583 | ﹤0.01% | 933 |
|
|
2021
Q1 | $342K | Sell |
3,512
-10,734
| -75% | -$1.05M | ﹤0.01% | 907 |
|
|
2020
Q4 | $1.37M | Buy |
14,246
+818
| +6% | +$78.4K | 0.01% | 567 |
|
|
2020
Q3 | $1.29M | Buy |
13,428
+10,053
| +298% | +$967K | 0.01% | 530 |
|
|
2020
Q2 | $412K | Hold |
3,375
| – | – | ﹤0.01% | 722 |
|
|
2020
Q1 | $292K | Hold |
3,375
| – | – | ﹤0.01% | 739 |
|
|
2019
Q4 | $363K | Buy |
3,375
+194
| +6% | +$20.9K | ﹤0.01% | 806 |
|
|
2019
Q3 | $287K | Hold |
3,181
| – | – | ﹤0.01% | 859 |
|
|
2019
Q2 | $269K | Hold |
3,181
| – | – | ﹤0.01% | 900 |
|
|
2019
Q1 | $280K | Hold |
3,181
| – | – | ﹤0.01% | 865 |
|
|
2018
Q4 | $227K | Hold |
3,181
| – | – | ﹤0.01% | 885 |
|
|
2018
Q3 | $391K | Hold |
3,181
| – | – | ﹤0.01% | 773 |
|
|
2018
Q2 | $313K | Buy |
3,181
+215
| +7% | +$21.2K | ﹤0.01% | 816 |
|
|
2018
Q1 | $246K | Hold |
2,966
| – | – | ﹤0.01% | 882 |
|
|
2017
Q4 | $230K | Buy |
+2,966
| New | +$230K | ﹤0.01% | 942 |
|